VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

SABCS 2020 | Key trial updates from SABCS 2020

Komal Jhaveri, MD, FACP, Memorial Sloan Kettering Cancer Center, New York, NY, explores practice changing data presented at this years annual San Antonio Breast Cancer Symposium (SABCS), these include the results of the RxPONDER trial which evaluated whether chemotherapy could be spared in women with node-positive early stage breast cancer based on OncoType Dx ® score. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter